Impact of clinical fractures on health-related quality of life is dependent on time of assessment since fracture: results from the FREEDOM trial

Authors :: A. Wang
Jean-Pierre Simon
S Ragi-Eis
Paul Lips
Dennis A. Revicki
S. Silverman
S Palacios Gil-Antuñano
Michael C. Nevitt
D. Macarios
Karel Pavelka
N. Gilchrist
Ethel S. Siris
Hema N. Viswanathan
Y-C Yang
Steven Boonen
Patrice Fardellone
Research Institute MOVE
Internal medicine
MOVE Research Institute
Source :: Silverman, S, Viswanathan, H N, Yang, Y, Wang, A, Boonen, S, Ragi-Eis, S, Fardellone, P, Gilchrist, N & Lips, P T A M 2012, ' Impact of clinical fractures on health-related quality of life is dependent on time of assessment since fracture: results from the FREEDOM-trial ', Osteoporosis International, vol. 23, no. 4, pp. 1361-1369 . https://doi.org/10.1007/s00198-011-1720-0, Osteoporosis International, 23(4), 1361-1369. Springer London
Publication Year :: 2011
Publisher :: Springer Science and Business Media LLC, 2011.
Abstract: Summary In the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) study, women with incident clinical fractures reported significant declines in health-related quality of life (HRQoL). The largest declines were observed when the assessment was

Tools